Ivermectin 3 mg is an antiparasitic medication approved in many countries for specific human parasitic infections. It is most commonly used to treat conditions such as strongyloidiasis (an intestinal roundworm infection) and onchocerciasis (river blindness). In certain regions  Ivermectin 3 mg may also be prescribed for scabies and lice infestations when first-line treatments are not effective or appropriate. The medication works by paralyzing and killing parasites, disrupting their ability to survive within the human body. For approved uses, Ivermectin is typically given as a single oral dose based on body weight, though the exact dosage regimen may vary depending on the infection being treated. Because effectiveness and safety depend on accurate dosing, a healthcare professional must determine the appropriate amount and schedule. The 3 mg tablet is a standard strength that can be combined to achieve the required dose. Although usually well tolerated, Ivermectin can cause side effects such as dizziness, nausea, fatigue, or mild skin reactions. In certain parasitic diseases—particularly onchocerciasis some symptoms after treatment may result from the body’s reaction to dying parasites rather than the drug itself. Individuals with underlying medical conditions, pregnant or breastfeeding people, or those taking other medications should consult a healthcare provider before use.